Do I need to take avatrombopag all the time?
Avatrombopag (Avatrombopag ) is an oral thrombopoietin receptor agonist, mainly used to treat preoperative thrombocytopenia symptoms in patients with chronic liver disease. There are several aspects to consider regarding whether avatrombopag needs to be continued.
First, whether avatrombopag needs to be continued usually depends on the patient's specific situation and the recommendations of the doctor. In some cases, patients may only need to take avatrombopag for a period of time before surgery to increase their platelet count to reduce the risk of surgery-related bleeding. Once the surgery is complete, continued use of this medication may not be necessary.
However, in other circumstances, particularly in patients with chronic liver disease, long-term or continued use of avatropopag may be needed to maintain a more stable platelet count. Patients with chronic liver disease often have thrombocytopenia, which may increase the risk of bleeding. Therefore, doctors may recommend that patients continue taking avatrombopag before surgery and continue it after surgery to maintain adequate platelet counts.

In addition, the use of avatrombopag may need to be adjusted based on the patient's condition. Doctors may monitor a patient's platelet count regularly and adjust the drug dose or discontinue use as needed. If a patient's liver function improves or other treatments respond, long-term use of avatropopag may no longer be necessary.
During the use of avatrombopag, patients should closely follow the doctor's instructions and have regular follow-up visits to ensure efficacy and safety. At the same time, patients should also pay attention to possible side effects caused by drugs and report any adverse reactions to their doctors in a timely manner.
In summary, whether avatrombopag needs to be continued depends on the patient's specific situation and the doctor's recommendations. In some cases, only short-term use may be necessary, while in other cases long-term or continuous use may be required to maintain adequate platelet counts. Patients should closely follow their doctor's instructions and have regular follow-up visits to ensure optimal treatment results.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)